rs767333157

Variant summary

Our verdict is Likely benign. The variant received -2 ACMG points: 3P and 5B. PM1PP2BP4_StrongBP6

The NM_000500.9(CYP21A2):​c.1306C>T​(p.Arg436Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00089 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00084 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

CYP21A2
NM_000500.9 missense

Scores

4
6
4

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:3B:1

Conservation

PhyloP100: 0.448

Publications

4 publications found
Variant links:
Genes affected
CYP21A2 (HGNC:2600): (cytochrome P450 family 21 subfamily A member 2) This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and hydroxylates steroids at the 21 position. Its activity is required for the synthesis of steroid hormones including cortisol and aldosterone. Mutations in this gene cause congenital adrenal hyperplasia. A related pseudogene is located near this gene; gene conversion events involving the functional gene and the pseudogene are thought to account for many cases of steroid 21-hydroxylase deficiency. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
TNXB (HGNC:11976): (tenascin XB) This gene encodes a member of the tenascin family of extracellular matrix glycoproteins. The tenascins have anti-adhesive effects, as opposed to fibronectin which is adhesive. This protein is thought to function in matrix maturation during wound healing, and its deficiency has been associated with the connective tissue disorder Ehlers-Danlos syndrome. This gene localizes to the major histocompatibility complex (MHC) class III region on chromosome 6. It is one of four genes in this cluster which have been duplicated. The duplicated copy of this gene is incomplete and is a pseudogene which is transcribed but does not encode a protein. The structure of this gene is unusual in that it overlaps the CREBL1 and CYP21A2 genes at its 5' and 3' ends, respectively. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
TNXB Gene-Disease associations (from GenCC):
  • Ehlers-Danlos syndrome
    Inheritance: AR Classification: DEFINITIVE Submitted by: G2P
  • Ehlers-Danlos syndrome due to tenascin-X deficiency
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Illumina, Genomics England PanelApp, PanelApp Australia
  • familial vesicoureteral reflux
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • vesicoureteral reflux 8
    Inheritance: AD Classification: LIMITED Submitted by: Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -2 ACMG points.

PM1
In a hotspot region, there are 4 aminoacids with missense pathogenic changes in the window of +-8 aminoacids around while only 0 benign, 2 uncertain in NM_000500.9
PP2
Missense variant in the gene, where a lot of missense mutations are associated with disease in ClinVar. The gene has 52 curated pathogenic missense variants (we use a threshold of 10). The gene has 5 curated benign missense variants. Trascript score misZ: 1.8021 (below the threshold of 3.09). GenCC associations: The gene is linked to classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, simple virilizing form, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, salt wasting form.
BP4
Computational evidence support a benign effect (MetaRNN=0.015557289).
BP6
Variant 6-32040952-C-T is Benign according to our data. Variant chr6-32040952-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 193595.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000500.9. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CYP21A2
NM_000500.9
MANE Select
c.1306C>Tp.Arg436Cys
missense
Exon 10 of 10NP_000491.4
CYP21A2
NM_001128590.4
c.1216C>Tp.Arg406Cys
missense
Exon 9 of 9NP_001122062.3P08686-2
CYP21A2
NM_001368143.2
c.901C>Tp.Arg301Cys
missense
Exon 10 of 10NP_001355072.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CYP21A2
ENST00000644719.2
MANE Select
c.1306C>Tp.Arg436Cys
missense
Exon 10 of 10ENSP00000496625.1P08686-1
CYP21A2
ENST00000960600.1
c.1342C>Tp.Arg448Cys
missense
Exon 10 of 10ENSP00000630659.1
CYP21A2
ENST00000960597.1
c.1315C>Tp.Arg439Cys
missense
Exon 10 of 10ENSP00000630656.1

Frequencies

GnomAD3 genomes
AF:
0.000889
AC:
134
AN:
150780
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000218
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00125
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.0196
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000104
Gnomad OTH
AF:
0.00145
GnomAD2 exomes
AF:
0.00214
AC:
287
AN:
134056
AF XY:
0.00187
show subpopulations
Gnomad AFR exome
AF:
0.000452
Gnomad AMR exome
AF:
0.0000817
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0259
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000211
Gnomad OTH exome
AF:
0.000489
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.000839
AC:
868
AN:
1034512
Hom.:
0
Cov.:
15
AF XY:
0.000789
AC XY:
414
AN XY:
524402
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.000110
AC:
3
AN:
27290
American (AMR)
AF:
0.0000567
AC:
2
AN:
35266
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
23202
East Asian (EAS)
AF:
0.0193
AC:
651
AN:
33714
South Asian (SAS)
AF:
0.000148
AC:
11
AN:
74188
European-Finnish (FIN)
AF:
0.0000259
AC:
1
AN:
38668
Middle Eastern (MID)
AF:
0.000277
AC:
1
AN:
3614
European-Non Finnish (NFE)
AF:
0.000162
AC:
122
AN:
751790
Other (OTH)
AF:
0.00165
AC:
77
AN:
46780
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.281
Heterozygous variant carriers
0
82
164
245
327
409
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.000888
AC:
134
AN:
150896
Hom.:
0
Cov.:
33
AF XY:
0.000733
AC XY:
54
AN XY:
73630
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.000217
AC:
9
AN:
41492
American (AMR)
AF:
0.00125
AC:
19
AN:
15210
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3438
East Asian (EAS)
AF:
0.0194
AC:
95
AN:
4892
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4810
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10402
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
290
European-Non Finnish (NFE)
AF:
0.000104
AC:
7
AN:
67358
Other (OTH)
AF:
0.00191
AC:
4
AN:
2094
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.301
Heterozygous variant carriers
0
8
17
25
34
42
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000528
Hom.:
0
ExAC
AF:
0.000313
AC:
15

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
2
-
ADRENAL HYPERPLASIA, CONGENITAL, DUE TO 21-HYDROXYLASE DEFICIENCY (2)
-
1
1
not provided (2)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.29
BayesDel_addAF
Benign
-0.12
T
BayesDel_noAF
Uncertain
0.070
CADD
Uncertain
24
DANN
Pathogenic
1.0
Eigen
Uncertain
0.54
Eigen_PC
Uncertain
0.39
FATHMM_MKL
Benign
0.28
N
MetaRNN
Benign
0.016
T
MetaSVM
Uncertain
0.21
D
PhyloP100
0.45
PrimateAI
Uncertain
0.76
T
PROVEAN
Pathogenic
-5.5
D
REVEL
Uncertain
0.61
Sift
Pathogenic
0.0
D
Sift4G
Pathogenic
0.0
D
Polyphen
1.0
D
Vest4
0.77
MutPred
0.92
Loss of methylation at R436 (P = 0.0139)
MVP
0.93
MPC
3.5
ClinPred
0.16
T
GERP RS
4.5
gMVP
0.68
Mutation Taster
=31/69
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs767333157; hg19: chr6-32008729; COSMIC: COSV64478243; COSMIC: COSV64478243; API